当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Kevin Matheri, Nyamu, Amugune
Objectives: To describe the prescribing patterns and identify correlates of prescribing antipsychotic. Design: A hospital-based cross-sectional study. Setting: A leading mental hospital in Kenya. Subjects: Adult patients receiving care for psychiatric illnesses Outcome Measures: The patients’ sociodemographic profile and antipsychotic prescribing data were recorded and associations between the two were computed at P≤ 0.05. Results: The mean age of the participants was 36.7 (SD 13.4) years and a majority were males (64.7%). Most prescriptions contained first-generation antipsychotics (FGAs) (79.2%), and almost half (45.2%) had second-generation antipsychotics. Most patients (53.7%) used supramaximal doses, which was significantly associated with polypharmacy of FGAs (P<0.001). Prescribing more than one FGA significantly increased the odds of having a supramaximal dose by 18 times (P<0.001). Conclusion: Polypharmacy especially with FGAs and use of supramaximal doses was prevalent. Future studies should develop a scaled guideline that informs the clinical efficacy of various doses of chlorpromazine equivalents.